BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
+11.92%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.61B
AUM Growth
+$85.8M
(+5.6%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
8.61%
Top 10 Holdings %
Top 10 Hldgs %
76.11%
Holding
34
New
4
Increased
2
Reduced
3
Closed
1
Top Buys
| 1 |
Rapid Micro Biosystems
RPID
|
+$156M |
| 2 |
Invivyd
IVVD
|
+$105M |
| 3 |
Nuvalent
NUVL
|
+$77.3M |
| 4 |
Tango Therapeutics
TNGX
|
+$12.9M |
| 5 |
ARYE
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
|
+$4.94M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
+$67.2M |
| 2 |
Dynavax Technologies
DVAX
|
+$64.5M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$63.4M |
| 4 |
Kymera Therapeutics
KYMR
|
+$23.3M |
Sector Composition
| 1 | Healthcare | 92.57% |
| 2 | Financials | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARYD
26
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $7.04M | 0.44% |
700,000
| – | – |
|
|
ARYE
27
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $4.94M | 0.31% |
+500,000
| New | +$4.94M |
|
|
PANA
28
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $4.89M | 0.3% |
500,000
| – | – |
|
|
BLSA
29
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $4.86M | 0.3% |
487,500
| – | – |
|
|
OMEG
30
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $3.89M | 0.24% |
400,000
| – | – |
|
|
FLACU
31
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
| $3.01M | 0.19% |
300,000
| – | – |
|
|
JYAC
32
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $2.93M | 0.18% |
300,000
| – | – |
|
33
MoonLake Immunotherapeutics
MLTX
$3.34B
| $2.49M | 0.15% |
250,000
| – | – |
|
|
34
Kymera Therapeutics
KYMR
$3.36B
| – | – |
-479,605
| Closed | -$23.3M |
|